reported on an interesting study in which they assessed the rates of psychiatric disorders in schizophrenia patients with and without obsessive-compulsive disorders (OCD) and pure OCD patients. Body dysmorphic disorder, tic disorders (TD), and anxiety disorders were found in higher frequencies in the schizo-obsessive group when compared to pure schizophrenia. The findings support the notion that the schizo-obssesive group may be an intermediate phenotype between schizophrenia and OCD. We would like to comment on the specific findings of TD. Curiously, the authors found no cases of Tourette syndrome in the schizo-obsessive group, while the odds of having chronic motor tics in the schizo-obsessive group (16%) were 4 times higher than those of the schizophrenia group (4%). In the OCD group, the frequency of TD was the classical 34.3% found in the literature. 2 The intermediate frequency of TD in the schizo-obsessive group speaks for a continuum between these disorders. One explanation for these higher frequencies of obsessive spectrum disorders could be the presence of common vulnerability genes.
Dear Editor:
Dr Michael Poyurovsky and coauthors 1 reported on an interesting study in which they assessed the rates of psychiatric disorders in schizophrenia patients with and without obsessive-compulsive disorders (OCD) and pure OCD patients. Body dysmorphic disorder, tic disorders (TD), and anxiety disorders were found in higher frequencies in the schizo-obsessive group when compared to pure schizophrenia. The findings support the notion that the schizo-obssesive group may be an intermediate phenotype between schizophrenia and OCD. We would like to comment on the specific findings of TD. Curiously, the authors found no cases of Tourette syndrome in the schizo-obsessive group, while the odds of having chronic motor tics in the schizo-obsessive group (16%) were 4 times higher than those of the schizophrenia group (4%). In the OCD group, the frequency of TD was the classical 34.3% found in the literature. 2 The intermediate frequency of TD in the schizo-obsessive group speaks for a continuum between these disorders. One explanation for these higher frequencies of obsessive spectrum disorders could be the presence of common vulnerability genes.
There are few reports of Tourette patients who later developed schizophrenia and also few reports of TD in schizophrenia. [3] [4] [5] The low frequency of TD in schizophrenia could be owing to a real low incidence of tic disorders in schizophrenia, the use of antipsychotics in schizophrenia patients that would mask tics when present, and tics that may be misdiagnosed as stereotypic behaviors, tardive diskinesia, and other extrapiramidal symptoms that might also lead to an underestimation of TD frequencies. 6 To rule out these factors, the authors could have informed medication use in the 3 groups of patients as well as the diagnostic criteria used to differentiate between several involuntary movement disorders.
The age of onset of the disorder, used as a covariable, showed no difference between OCD and schizo-obsessive patients. This is another important factor that reinforces the hypothesis that schizo-obsessive, have a place between schizophrenia and OCD, sharing specific comorbidity patterns with both.
A comparable proportion of patients in our schizophrenia groups with and without OCD were treated with typical (31 and 39, respectively) and atypical (69 and 61, respectively) antipsychotic agents. Moreover, average dosages of antipsychotics, as assessed by the Defined Daily Dosages 1 in the 2 groups were also remarkably similar (typical: 1.24, SD 0.76, and 1.16, SD 0.52, t = 0.88, df = 98, P = 0.39; atypical: 1.10, SD 0.51, and 1.12, SD 0.36, t = 0.32; df = 98, P = 0.75). Hence, it is unlikely that a "masking" effect of antipsychotic agents on CTD accounts for the revealed between-group difference in the rate of CTD. It is also implausible that the misdiagnoses of tics and tardive dyskinesia or other extrapyramidal side effects explain the higher rate of CTD in the schizo-obsessive group, since no between-group differences in scores of Barnes Akathisia Scale (BAS) and Abnormal Involuntary Movement (AIMS) were noted (BAS: 0.17, SD 0.50, and 0.26 SD 0.94, t = 0.85, df = 98, P = 0.40; AIMS: 0.69, SD 2.41, and 1.34 SD, 1.38, t =1.62, df = 98, P = 0.11).
As expected, significantly more patients in our schizoobsessive group than in the schizophrenia group received selective serotonin reuptake inhibitors (SSRIs) (42 and 13, respectively, ÷ 2 = 21.09, P <0.001). There are few reports indicating that SSRIs may induce tics in patients with primary diagnoses of OCD, anxiety or mood disorders. 2, 3 Although the possibility that a preferential use of SSRIs in our schizo-obsessive group may account for the increased CDT rate can not be disregarded, this seems unlikely because in all patients chronic tics were detected well before the initiation of SSRIs.
We believe that a revealed predominant aggregation of CTD in schizophrenia patients with OCD represents a "true"
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